1.56 -0.15 (-8.77%)

52.73% Fall from 52W High

70,885 XNAS Volume

High volume+loss today

XNAS 17 Mar, 2025 5:30 PM (EDT)



Insider Trading disclosures for Anebulo Pharmaceuticals Inc

The latest disclosure was made by R. Aron English in Anebulo Pharmaceuticals Inc where a trade of 10,101,010 Common Stock done at an average price of $1.0 was reported to US exchanges on Dec. 23, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
R. Aron English Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.99 per share. 23 Dec 2024 10,101,010 15,467,300 - 1.0 10,000,000 Common Stock
Richard Anthony Cunningham Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 254,433 254,433 - - Stock Option (right to buy)
Aron R. English Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 41,667 41,667 - - Stock Option (right to buy)
Jason M. Aryeh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 2,482 2,482 - - Stock Option (right to buy)
Jason M. Aryeh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 41,667 41,667 - - Stock Option (right to buy)
Bimal R. Shah Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 41,667 41,667 - - Stock Option (right to buy)
Bimal R. Shah Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 3,309 3,309 - - Stock Option (right to buy)
Joseph F. Lawler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 6,618 6,618 - - Stock Option (right to buy)
Joseph F. Lawler Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 41,667 41,667 - - Stock Option (right to buy)
Aron R. English Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 1,324 1,324 - - Stock Option (right to buy)
Areta Kupchyk Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 41,667 41,667 - - Stock Option (right to buy)
Areta Kupchyk Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 1,324 1,324 - - Stock Option (right to buy)
Kenneth Lin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 41,667 41,667 - - Stock Option (right to buy)
Kenneth Lin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 2,482 2,482 - - Stock Option (right to buy)
Nathaniel Calloway Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 1,655 1,655 - - Stock Option (right to buy)
Nathaniel Calloway Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 41,667 41,667 - - Stock Option (right to buy)
Kenneth C. Cundy Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Feb 2024 72,613 72,613 - - Stock Option (right to buy)
Kenneth C. Cundy Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Feb 2024 72,613 72,613 - - Stock Option (right to buy)
Aron R. English Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Nov 2023 300,000 300,000 - 0 Common Stock
R. Aron English Director, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 13 Nov 2023 300,000 0 - 0 Common Stock
Aron English R. Director, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 13 Nov 2023 300,000 5,366,290 - 0 Common Stock
Simon Allen Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2022 70,246 70,246 - - Stock Option (right to buy)
Kenneth C. Cundy Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2022 35,017 35,017 - - Stock Option (right to buy)
Nat Calloway Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Nov 2022 59,149 59,149 - - Stock Option (right to buy)
Simon Allen Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2022 77,457 77,457 - - Stock Option (right to buy)
Kenneth C. Cundy Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 350,169 350,169 - - Option to purchase Common Stock
Karah Parschauer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2022 30,425 30,425 - - Stock Option (right to buy)
Areta Kupchyk Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2022 30,425 30,425 - - Stock Option (right to buy)
Kenneth Lin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2022 30,425 30,425 - - Stock Option (right to buy)
Jason M. Aryeh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2022 30,425 30,425 - - Stock Option (right to buy)
Joseph F. Lawler Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2022 30,425 30,425 - - Stock Option (right to buy)
Simon Allen Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2022 625,000 625,000 - - Option to purchase Common Stock
Aron R. English Director, Ten Percent Owner, See Explanation of Responses Purchase of securities on an exchange or from another person at price $ 5.90 per share. 14 Dec 2021 412 3,362,313 - 5.9 2,429 Common Stock, par value $0.001 per share
Aron R. English Director, Ten Percent Owner, See Explanation Response Purchase of securities on an exchange or from another person at price $ 5.30 per share. 02 Dec 2021 13,836 3,357,401 - 5.3 73,331 Common Stock, par value $0.001 per share
Aron R. English Director, Ten Percent Owner, See Explanation of Responses Grant, award, or other acquisition of securities at price $ 7.00 per share. 06 May 2021 714,250 3,343,565 - 7 4,999,750 Common Stock, par value $0.001 per share
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures